Welcome New Members September 2022!

We would like to introduce the Members who joined ISPE in September 2022, welcome them to the Chapter and encourage them (and all our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And the ISPE Membership Directory is a great way to connect with fellow ISPE members. We encourage all members, current and new, to get involved with the Chapter’s many committees, educational programs, and social activities. Visit our website for more information and don’t forget to subscribe to our blog for up-to-date information on our industry, Chapter activities and much more. And to all our members, we value your input, so please email us at office@ispeboston.org with your feedback and questions. We look forward to hearing from you.

JAdeel Ahmed, Azzur Group
Ashutosh Anand, Tufts University
Brianna Aubin, Bristol-Myers Squibb
Serena Bodner, Alnylam Pharmaceuticals, Inc.
Jeffrey Bowler, EnableLifeSciences LLC
Vanessa Bush
Bo Caldwell
Joseph Camilo, Tocco
Jessica Carbonneau
Cameron Carlin, Worcester Polytechnic Institute
Kofi Colecraft, Synspira Therapeutics
James Dahill, Commodore Builders
Patrick Doan, CAI
Drazen Doutlik, Seven Bridges Genomics Inc.
Anthony Dubey
Bryan Ennis, BTR
Alison Farmer, Vertex Pharmaceuticals
Patricia Forrester
Luz Frazier, Lead Humano
Gerardo Gomez, PharmaLex
Megan Guros
Lindsey Helsel
Ebony Joseph
Ryan Kazijian
Meghal Keskar, Ocular Therapeutix
Ken Kuchnir
Britni Lamontagne, Watson Marlow Fluid Technology Solutions
Sharon Lee
Caitlin Looney
Jose Martinhao
Maxwell McHugh
Sharon Miller
Mahesh Murthy
Kamil Obrycki, Uri
Richard Otis, Novo Nordisk
Matthew Rosi
Katherine Schweizer, MassBio
Stephanie Shepard, Element
Daniel Smith
Stephen Smith
Mark Somerville, American Technologies, Inc.
Jing Song
Peter Sylvain
Sai Tadiboina, CSL Behring
Karim Touati, MCPHS
Mariel Ulichney
Brendan Walker, Moderna Therapeutics
Shengyi Wang, Moderna Therapeutics
Sean Williams